You are using an older browser version. Please use a supported version for the best MSN experience.

ANIKA THERAPEUTICS, INC.

NASDAQ: ANIK
52.72
-0.41
-0.76%

Sector

Healthcare

Industry

Pharmaceuticals

Anika Therapeutics, Inc. is an orthopedic medicines company. The Company is engaged in developing, manufacturing and commercializing products based on its hyaluronic acid (HA) technology. The Company's orthopedic medicine portfolio includes ORTHOVISC, MONOVISC, and CINGAL, which alleviate pain and restore joint function by replenishing depleted HA, and HYALOFAST, a solid HA-based scaffold to aid cartilage repair and regeneration. The Company's therapeutic offerings consist of products in the areas, including Orthobiologics, which includes viscosupplementation and regenerative orthopedic products; Dermal, which includes wound care products; Surgical, which includes products used to prevent post-surgical adhesions, and Other, which includes the Company's ophthalmic and veterinary products. The Company also offers products made from HA based on two other technologies: HYAFF, which is a solid form of HA, and ACP gel, an autocross-linked polymer of HA.

Key People

Joseph Darling

President, Chief Executive Officer, Director

Sylvia Cheung

Chief Financial Officer, Treasurer, Secretary

Edward Ahn

Chief Technology and Strategy Officer

Richard Hague

Chief Commercial Officer

Joseph Bower

Lead Director, Independent Director

Incorporated

2018

Employees

133

Insider Trades
  • Recent
  • All
  • Date

  • Name

  • Transaction

  • Shares

  • Price(s)

  • Value

    • 8/28/2019

    • LARSEN (GLENN R)

    • Sold

    • 4,355

    • 57.21

    • 249,149.55

    • 8/20/2019

    • BOWER JOSEPH L

    • Sold

    • 1,994

    • 55.57

    • 110,806.58

    • 7/29/2019

    • LAND RAYMOND J

    • Sold

    • 3,000

    • 55.44

    • 166,320.00

    • 2/28/2019

    • DARLING JOSEPH G

    • Bought

    • 1,000

    • 33.20

    • 33,200.00

    • 2/26/2019

    • LAND RAYMOND J

    • Grant

    • 3,842

    • NA

    • NA

    • 2/26/2019

    • LAND RAYMOND J

    • Sold

    • 4,000

    • 33.06

    • 132,240.00

    • 2/26/2019

    • THOMPSON JEFFERY SCOTT

    • Grant

    • 3,842

    • NA

    • NA

    • 2/26/2019

    • LARSEN (GLENN R)

    • Grant

    • 3,842

    • NA

    • NA

    • 2/26/2019

    • VOGT SUSAN L N

    • Grant

    • 3,842

    • NA

    • NA

    • 2/26/2019

    • BOWER JOSEPH L

    • Grant

    • 3,842

    • NA

    • NA

    • 2/26/2019

    • BLANCHARD CHERYL R

    • Grant

    • 3,842

    • NA

    • NA

    • 10/23/2018

    • VOGT SUSAN L N

    • Grant

    • 3,703

    • NA

    • NA

    • Date

    • Name

    • Transaction

    • Shares

    • Price(s)

    • Value

      • 8/28/2019

      • LARSEN (GLENN R)

      • Sold

      • 4,355

      • 57.21

      • 249,149.55

      • 8/20/2019

      • BOWER JOSEPH L

      • Sold

      • 1,994

      • 55.57

      • 110,806.58

      • 7/29/2019

      • LAND RAYMOND J

      • Sold

      • 3,000

      • 55.44

      • 166,320.00

      • 2/28/2019

      • DARLING JOSEPH G

      • Bought

      • 1,000

      • 33.20

      • 33,200.00

      • 2/26/2019

      • LAND RAYMOND J

      • Grant

      • 3,842

      • NA

      • NA

      • 2/26/2019

      • LAND RAYMOND J

      • Sold

      • 4,000

      • 33.06

      • 132,240.00

      • 2/26/2019

      • THOMPSON JEFFERY SCOTT

      • Grant

      • 3,842

      • NA

      • NA

      • 2/26/2019

      • LARSEN (GLENN R)

      • Grant

      • 3,842

      • NA

      • NA

      • 2/26/2019

      • VOGT SUSAN L N

      • Grant

      • 3,842

      • NA

      • NA

      • 2/26/2019

      • BOWER JOSEPH L

      • Grant

      • 3,842

      • NA

      • NA

      • 2/26/2019

      • BLANCHARD CHERYL R

      • Grant

      • 3,842

      • NA

      • NA

      • 10/23/2018

      • VOGT SUSAN L N

      • Grant

      • 3,703

      • NA

      • NA

      AdChoices
      AdChoices
      AdChoices
      image beaconimage beaconimage beacon